Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Carbimazole

Agranulocytosis

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Schempp V, et al. Neutropenia in paediatric Graves disease patients occurs more often under Carbimazole than Methimazole. Hormone Research in Paediatrics 96 (Suppl.): 435-436 abstr. P1-388, Sep 2023. Available from: URL: https://dx.doi.org/10.1159/000533803 [abstract] Schempp V, et al. Neutropenia in paediatric Graves disease patients occurs more often under Carbimazole than Methimazole. Hormone Research in Paediatrics 96 (Suppl.): 435-436 abstr. P1-388, Sep 2023. Available from: URL: https://dx.doi.org/10.1159/000533803 [abstract]
Metadaten
Titel
Carbimazole
Agranulocytosis
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56757-2

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Calcium

Case report

Sirolimus

Case report

Tacrolimus

Case report

Pembrolizumab

Case report

Ketamine